About this trial
This is a registry of the patients that are admitted to CICU and treated by the Scientific Staff of the 2nd Department of Cardiology, due to an acute cardiovascular disease (acute coronary syndrome, acute heart failure, arrhythmia, pulmonary embolism, cardiac tamponade etc) in order to investigate the clinical characteristics of the patients, their outcome, identify the factors that could predict the in-hospital mortality and compare the results with the predicted by established risk scores. Furthermore, the study will investigate the one-year mortality and also the major adverse cardiac events (MACE - acute myocardial infarction, stroke, or cardiovascular death) will be measured.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients admitted to the Cardiac Intensive Care Unit (CICU) through the Emergency Department of the UHI
All patients transferred to the CICU from other hospital departments or other regional secondary hospitals
Patients with an acute cardiovascular disease that requires treatment in a CICU
Patients who are under scientific supervision of the 2nd Department of Cardiology
Disqualifiers
None
Trial population
All patients that are admitted through the Emergency Department of the UHI, transferred by other hospital clinics or by other regional secondary hospitals, with an acute cardiovascular disease that requires treatment in a CICU and are under scientific supervision of the 2nd Department of Cardiology, irrespectively of gender and age. In order to be enrolled, patients or their relative/legal representative (in cases stated above) must have signed an informed consent form
Trial design
Cohort
Prospective
Treatments tested in this trial
Admission in the Cardiac Intensive Care Unit (CICU)
Other interventionall patients admitted in the CICU will be enrolled in the study provided they give their informed consent.
Treatment groups
Trial outcomes
Primary outcomes
In-hospital mortality
In-hospital all-cause mortality of patients with acute cardiovascular disease that require treatment in a CICU
30-day mortality
30-day all-cause mortality of patients with acute cardiovascular disease that require treatment in a CICU
1-year mortality
1-year all-cause mortality of patients with acute cardiovascular disease that require treatment in a CICU
Secondary outcomes
In-hospital major adverse cardiac events (MACE)
In-hospital MACE of patients with acute cardiovascular disease that require treatment in a CICU
30-day major adverse cardiac events (MACE)
30-day MACE of patients with acute cardiovascular disease that require treatment in a CICU
1-year major adverse cardiac events (MACE)
1-year MACE of patients with acute cardiovascular disease that require treatment in a CICU
Sponsors and contacts
Click on the lead sponsor to view all of their trials.